Drug recall · February 21, 2018
Klonopin recall
Why: Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01
- Lots / codes
Lot # 3141989, EXP 08/31/2019
- Quantity
- 3,192 bottles
- Company
- Genentech, Inc., South San Francisco, CA
- Distribution
- Distributed throughout the United States
- Initiated
- February 5, 2018 · Voluntary: Firm initiated
- Classified
- February 13, 2018
- Reported
- February 21, 2018
- Ended
- September 6, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.